Efficacy of repeated low-dose bevacizumab treatment with long-dosing interval for radiation-induced brain necrosis: A case report

References

• Nonoguchi N, Miyatake S, Fukumoto M, Furuse M, Hiramatsu R, Kawabata S, Kuroiwa T, Tsuji M, Fukumoto M, Ono K. The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neuro-Oncol 2011; 105:423-31; PMID:21688077; http://dx.doi.org/10.1007/s11060-011-0610-9
   PubMed Web of Science ®Google Scholar
• Gonzalez J, Kumar AJ, Conrad CA, Levin VA. Effect of bevacizumab on radiation necrosis of the brain. Inter J Radiat Oncol Biol Phys 2007; 67:323-6; PMID:17236958; http://dx.doi.org/10.1016/j.ijrobp.2006.10.010
   PubMed Web of Science ®Google Scholar
• Pillay Smiley N, Alden T, Hartsell W, Fangusaro J. Severe radiation necrosis successfully treated with bevacizumab in an infant with low-grade glioma and tumor-associated intractable trigeminal neuralgia. Pediat Blood Cancer 2016; 63(9):1671-3; PMID:27187113; http://dx.doi.org/10.1002/pbc.26055
   PubMed Web of Science ®Google Scholar
• Furuse M, Nonoguchi N, Kawabata S, Miyata T, Toho T, Kuroiwa T, Miyatake S. Intratumoral and peritumoral post-irradiation changes, but not viable tumor tissue, may respond to bevacizumab in previously irradiated meningiomas. Radiat Oncol (London, England) 2015; 10:156; PMID:26223253; http://dx.doi.org/10.1186/s13014-015-0446-0
   PubMed Web of Science ®Google Scholar
• Sadraei NH, Dahiya S, Chao ST, Murphy ES, Osei-Boateng K, Xie H, Suh JH, Peereboom DM, Stevens GH, Ahluwalia MS. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience. Am J Clin Oncol 2015; 38:304-10; PMID:23799286; http://dx.doi.org/10.1097/COC.0b013e31829c3139
   PubMed Web of Science ®Google Scholar
• Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Grewal J, Prabhu S, Loghin M, Gilbert MR, et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Internat J Radiat Oncol Biol Phys 2011; 79:1487-95; PMID:20399573; http://dx.doi.org/10.1016/j.ijrobp.2009.12.061
   PubMed Web of Science ®Google Scholar
• Du Four S, Hong A, Chan M, Charakidis M. Symptomatic histologically proven necrosis of brain following stereotactic radiation and ipilimumab in six lesions in four melanoma patients. 2014; 2014:417913.
   Google Scholar
• Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9:669-76; PMID:12778165; http://dx.doi.org/10.1038/nm0603-669
   PubMed Web of Science ®Google Scholar
• Schuttrumpf LH, Niyazi M, Nachbichler SB, Manapov F, Jansen N, Siefert A, Belka C. Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1-3 cerebral metastases. Radiat Oncol (London, England) 2014; 9:105; PMID:24885624; http://dx.doi.org/10.1186/1748-717X-9-105
   PubMed Web of Science ®Google Scholar
• Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM. Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J Neuro-Oncol 2011; 105:281-9; PMID:21603965; http://dx.doi.org/10.1007/s11060-011-0579-4
   PubMed Web of Science ®Google Scholar
• Amit L, Ben-Aharon I, Vidal L, Leibovici L, Stemmer S. The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors–a meta-analysis and systematic review. PloS One 2013; 8:e51780; PMID:23349675; http://dx.doi.org/10.1371/annotation/e3301fb2-ae1d-471a-aaf7-f38b4c989aff
   PubMed Web of Science ®Google Scholar
• Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA, Benson AB 3rd; Eastern Cooperative Oncology Group Study E3200. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007; 25:1539-44; PMID:17442997; http://dx.doi.org/10.1200/JCO.2006.09.6305
   PubMed Web of Science ®Google Scholar
• Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Eng J Med 2006; 355:2542-50; PMID:17167137; http://dx.doi.org/10.1056/NEJMoa061884
   PubMed Web of Science ®Google Scholar
• Miller KD, Chap LI, Holmes FA, Cobleigh MA, Marcom PK, Fehrenbacher L, Dickler M, Overmoyer BA, Reimann JD, Sing AP, et al. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol 2005; 23:792-9; PMID:15681523; http://dx.doi.org/10.1200/JCO.2005.05.098
   PubMed Web of Science ®Google Scholar
• Burger RA, Brady MF, Bookman MA, Fleming GF, Monk BJ, Huang H, Mannel RS, Homesley HD, Fowler J, Greer BE, et al. Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Eng J Med 2011; 365:2473-83; PMID:22204724; http://dx.doi.org/10.1056/NEJMoa1104390
   PubMed Web of Science ®Google Scholar
• Zhuang H, Yuan X, Zheng Y, Li X, Chang JY, Wang J, Wang X, Yuan Z, Wang P. A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis. Scient Rep 2016; 6:24364; PMID:27067388; http://dx.doi.org/10.1038/srep24364
   PubMed Web of Science ®Google Scholar
• Shen G, Wang YJ, Guan YJ, Dong DP, Yang G, Li D, Hao RM, Sun HR, Zhou M, Wang KP, et al. Relief effect of Bevacizumab on severe edema induced by re-irradiation in brain tumor patients. Chin Med J 2015; 128:2126-9; PMID:26228232; http://dx.doi.org/10.4103/0366-6999.161403
   PubMed Web of Science ®Google Scholar
• Zhuang H, Yuan X, Sun D, Bian J, Chang JY, Yuan Z, Wang P. Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report. Oncotarget 2016; 7:13265-8; PMID:26933810; http://dx.doi.org/10.18632/oncotarget.7724
   PubMed Web of Science ®Google Scholar